Login to Your Account



Albany Molecular, Bristol-Myers Rework Discovery Collaboration

By Karen Young


Wednesday, February 20, 2002
Albany Molecular Research Inc. signed a letter of intent with Bristol-Myers Squibb Co. to replace and consolidate Albany’s Molecular’s original agreement with DuPont Pharmaceuticals Co., in addition to signing a new agreement giving BMS access to AMRI’s natural products library. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription